Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Bone tumor Stories

2006-03-30 08:05:00

By Patricia Reaney LONDON -- Growth spurts during adolescence are associated with peaks in the incidence of some types of teenage cancers, researchers said on Thursday. Although cancer is rare in teenagers, it is the biggest cause of non-accidental death in 13-24 year olds. Four types of cancer, including two bone tumors, are more common in adolescents and young adults. Professor Jillian Birch, of the University of Manchester in England, told a conference in London that genetics, hormones and...

2006-03-30 05:15:00

By Patricia Reaney LONDON -- Growth spurts during adolescence are associated with peaks in the incidence of some types of teenage cancers, researchers said on Thursday. Although cancer is rare in teenagers, it is the biggest cause of non-accidental death in 13-24 year olds. Four types of cancer, including two bone tumors, are more common in adolescents and young adults. Professor Jillian Birch, of the University of Manchester in England, told a conference in London that genetics, hormones and...

2005-09-01 23:55:00

ANN ARBOR, Mich. "“ Prostate cancer is a cruel disease. Left untreated, prostate cancer cells often metastasize, or spread, to bone where they form fracture-prone tumors that are extremely painful. More than 80 percent of men who die from prostate cancer die with metastatic disease in their bones. But scientists know very little about how migrating prostate cancer cells set up housekeeping in bone tissue and produce the dense bony lesions characteristic of prostate cancer. Now, new...

2005-06-20 18:30:00

Massachusetts General Hospital (MGH) researchers have shown that radiofrequency ablation (RFA) "“ a minimally invasive way of destroying tissue "“ is an effective, longlasting treatment for small kidney tumors in selected patients. In a followup to research published in 2003, the investigators found that RFA treatment of renal cell carcinoma, the most common kidney cancer, continued to be successful 4 to 6 years after administration. The report appears in the July issue of the...

2004-11-25 03:00:18

Aim. The aim of this study was to determine if patients with lung cancer and metastatic bone pain due to disseminated secondary bone disease, can benefit from the treatment with ^sup 186^Re-HEDP and to discuss the criteria useful for selecting those patients. Methods. Twenty-four patients were included in this study and they received 1 295 MBq ^sup 186^Re-HEDP. All patients underwent ^sup 99m^Tc-MDP bone scan before treatment from which the bone scan index (BSI) was determined...